دورية أكاديمية

Female-selective mechanisms promoting migraine.

التفاصيل البيبلوغرافية
العنوان: Female-selective mechanisms promoting migraine.
المؤلفون: Singh, Shagun, Kopruszinski, Caroline M., Watanabe, Moe, Dodick, David W., Navratilova, Edita, Porreca, Frank
المصدر: Journal of Headache & Pain; 4/24/2024, Vol. 25 Issue 1, p1-10, 10p
مصطلحات موضوعية: NOCICEPTORS, PAIN measurement, SEX distribution, PROLACTIN, NEUROPEPTIDES, PAIN management, INDIVIDUALIZED medicine, MIGRAINE, NEUROTRANSMITTERS, CHEMICAL inhibitors
مستخلص: Sexual dimorphism has been revealed for many neurological disorders including chronic pain. Prelicinal studies and post-mortem analyses from male and female human donors reveal sexual dimorphism of nociceptors at transcript, protein and functional levels suggesting different mechanisms that may promote pain in men and women. Migraine is a common female-prevalent neurological disorder that is characterized by painful and debilitating headache. Prolactin is a neurohormone that circulates at higher levels in females and that has been implicated clinically in migraine. Prolactin sensitizes sensory neurons from female mice, non-human primates and humans revealing a female-selective pain mechanism that is conserved evolutionarily and likely translationally relevant. Prolactin produces female-selective migraine-like pain behaviors in rodents and enhances the release of calcitonin gene-related peptide (CGRP), a neurotransmitter that is causal in promoting migraine in many patients. CGRP, like prolactin, produces female-selective migraine-like pain behaviors. Consistent with these observations, publicly available clinical data indicate that small molecule CGRP-receptor antagonists are preferentially effective in treatment of acute migraine therapy in women. Collectively, these observations support the conclusion of qualitative sex differences promoting migraine pain providing the opportunity to tailor therapies based on patient sex for improved outcomes. Additionally, patient sex should be considered in design of clinical trials for migraine as well as for pain and reassessment of past trials may be warranted. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Headache & Pain is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:11292369
DOI:10.1186/s10194-024-01771-w